Skip to content

Study on the efficacy and mechanism of transcranial direct current stimulation combined with repetitive transcranial magnetic stimulation in the treatment of children with ASD

Study on the efficacy and mechanism of transcranial direct current stimulation combined with repetitive transcranial magnetic stimulation in the treatment of children with ASD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105443
Enrollment
Unknown
Registered
2025-07-03
Start date
2025-05-14
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

tDCS+ combined with rTMS+ :On the basis of behavioral training therapy, tDCS combined with rTMS therapy was used
tDCS+ combined with rTMS-:On the basis of behavioral training therapy, tDCS combined with rTMS-therapy was used
tDCS- combined with rTMS+:On the basis of behavioral training therapy, tDCS-combined with rTMS therapy was used
tDCS- combined with rTMS-:On the basis of behavioral training therapy, tDCS- combined with rTMS- therapy was used

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 2-12 years old; 2. Meet the DSM-5-based diagnostic criteria for ASD and confirmed by the Autism Diagnostic Observation Program Version 2 (ADOS-2); 3. Receiving behavioral rehabilitation therapy.

Exclusion criteria

Exclusion criteria: 1.With a history of epileptic seizures or epilepsy. 2. There is evidence of significant epileptiform activity on the electroencephalogram (EEG). 3. There is a history of severe (traumatic) brain injury. 4. Those with skull defects or unopened fontanelles. 5. Coexisting severe neurological or mental disorders. 6. Those with cochlear implants. 7. Those with metal foreign objects placed near the stimulation coil inside the skull. 8. Implantable devices: equipped with built-in pulse generators, pacemakers, implantable drug pumps, implantable defibrillators and implantable nerve stimulators, etc.

Design outcomes

Primary

MeasureTime frame
The total score of the Autism Treatment Evaluation Checklist (ATEC);

Secondary

MeasureTime frame
Griffiths Neurodevelopmental Assessment Gross Quotient and/or Sub-test developmental Quotient (2-6 years old);Wechsler Intelligence Test Total IQ and/or sub-test scores (6-12 years old);The total score and/or subscale scores of the Infantile - Junior High School Student Social Life Ability Scale (S-M Scale);Total score and/or sub-test score of DN: CAS Cognitive Assessment System (6-12 years old);The total score and/or subscale scores of the Social Responsiveness Scale (SRS) (aged 6-12);The total score and/or subscale score of the Autism Behavior Checklist (ABC);The total score of the Childhood Autism Rating Scale (CARS);The total score and/or subscale scores of the Child Behavior Checklist (CBCL);The total score and/or subscale scores of the Children's Sleep Habits Questionnaire (CSHQ);Changes in near-infrared resting-state brain functional connectivity;The changes of ERP latency and amplitude;

Countries

China

Contacts

Public ContactDong Hanyu

The First Hospital of Jilin University

donghanyu@jlu.edu.cn+86 159 4309 3246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026